Advances in sleep medicine, explained by the clinic's team.
Sleep Congress 2026
Lyon — 40th SFRMS edition
The annual gathering of sleep specialists: healthcare professionals, researchers and patient associations. La Clinique du Sommeil will attend this landmark 40th edition of the SFRMS congress in Lyon.
August 24, 2026
A recent study examines the association between cannabis use and signs of respiratory disorders during sleep among American adults. The results show a correlation, but causality remains to be established. Further research is needed to better understand this relationship.
A study explored the link between sleep disorders, mild cognitive decline, and frailty in adults with chronic pain. The results show that these disorders are associated with greater frailty, which could influence patient assessments and follow-ups.
A study evaluated the orexin receptor 2 agonist, alixorexton, for type 1 narcolepsy. This treatment showed significant improvements in alertness and cataplexy. Side effects were generally tolerable, paving the way for further studies.
A recent study suggests that sleeping too little or too much may be linked to faster body aging. Researchers observed that individuals sleeping between 6.4 and 7.8 hours per day showed the lowest levels of aging. Various health issues are also associated with inappropriate sleep durations.
August 22, 2026
A recent study showed that the combination of virtual reality and biofeedback improves sleep quality and daytime function in patients suffering from chronic insomnia. The results indicate a reduction in nighttime awakenings and an improvement in daytime fatigue, with no significant adverse effects.
August 7, 2026
A new portable patch could help achieve REM sleep more quickly and stay in it longer, without the use of medication or surgery. A study showed a reduction of 43 minutes in the time needed to reach this sleep phase.
July 31, 2026
A study reveals that maintaining a regular daily routine can help reduce pain and depression, particularly in older adults suffering from insomnia. Consistent schedules for waking, eating, socializing, and sleeping are associated with better well-being, regardless of sleep quality.
A recent study revealed that a gene linked to the brain's nighttime cleaning system may influence the impact of poor sleep on brain changes associated with Alzheimer's disease. This paves the way for more personalized prevention strategies.
July 20, 2026
A recent study revealed that immune cells in the brain, called microglia, may be responsible for sleep loss in people with Alzheimer’s disease. By temporarily modifying these cells, researchers observed an improvement in sleep without affecting amyloid plaques.
July 5, 2026
Researchers have identified a brain circuit that connects deep sleep to the release of growth hormone. This discovery explains how sleep, muscle growth, fat metabolism, and brain function influence each other. It could pave the way for new therapies for sleep disorders and certain diseases.
May 15, 2026
The SynAIRgy trial (phase 3, 646 patients) shows that a daily tablet significantly reduces apnoeas by strengthening the tone of the upper-airway muscles. A promising alternative to CPAP machines for patients who cannot tolerate them.
January 7, 2026
Stanford researchers have developed SleepFM, an AI able to analyse polysomnography data to predict the risk of cancers, heart disease, mental disorders and many other conditions — sometimes years before diagnosis.
